Lotus Bio-Technology Development Corp. (LBTD)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Lotus Bio-Technology Development Corp. (LBTD) trades at $0.01. Lotus Bio-Technology Development Corp. focuses on refining organic materials and producing natural consumer products in China. The company, formerly Starflick. Market cap: $8.06M, Sector: Basic materials.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for LBTD: LBTD does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates LBTD against Basic Materials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
LBTD: 1/1 perspectives are bearish.
How is this calculated? →Lotus Bio-Technology Development Corp. (LBTD) Materials & Commodity Exposure
Lotus Bio-Technology Development Corp., operating in the agricultural inputs sector, focuses on refining organic materials and producing natural consumer products in China. Formerly Starflick.com, the company's current operations are based in Cave Creek, Arizona, with a market capitalization of $8.06M.
What Is the Investment Thesis for LBTD?
Investing in Lotus Bio-Technology Development Corp. presents a high-risk, high-reward scenario. The company's focus on the Chinese market for organic products aligns with a growing consumer trend. However, the company's small market capitalization ($0.01 billion) and negative P/E ratio (-42.34) indicate significant financial challenges. Growth catalysts depend on successful product development and market penetration in China. Key risks include competition, regulatory hurdles, and the company's ability to secure adequate funding. Investors should carefully consider the OTC market risks and conduct thorough due diligence before investing. The company's beta of 2.02 suggests high volatility.
Based on FMP financials and quantitative analysis
LBTD Key Highlights
- Market capitalization of $8.06M indicates a micro-cap company.
- Negative P/E ratio of -42.34 reflects current losses or low profitability.
- Beta of 2.02 suggests the stock is more volatile than the market average.
- The company operates in the agricultural inputs sector, focusing on organic materials.
- No dividend is currently being paid, indicating a focus on reinvesting earnings.
Who Are LBTD's Competitors?
LBTD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BRKCF Barksdale Resources Corp. | $0.25 | -8.16% | $36.83M | 45 |
| GARWF Golden Arrow Resources Corporation | $0.07 | +12.50% | $11.44M | 42 |
| RMIOF Romios Gold Resources Inc. | $0.42 | -6.66% | $13.75M | 48 |
| MBII Marrone Bio Innovations, Inc. | $0.80 | -20.19% | 68 | |
| AGRZ Agroz Inc. | $0.39 | -2.16% | $8.45M | 61 |
| KNGW Kenongwo Group US, Inc. | $0.32 | +0.00% | $32.60M | 59 |
| BHST BioHarvest Sciences Inc. | $3.00 | +4.53% | $51.98M | 59 |
| HMIFF Harvest Minerals Limited | $0.06 | +0.00% | $29.69M | 41 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are LBTD's Key Strengths?
- Focus on growing organic market in China.
- Proprietary refining processes.
- Established presence in China.
- Alignment with consumer trends towards natural products.
What Are LBTD's Weaknesses?
- Small market capitalization.
- Negative P/E ratio.
- Limited financial resources.
- OTC market listing.
What Could Drive LBTD Stock Higher?
- Potential partnerships with Chinese distributors to expand market reach.
- Increasing demand for organic products in the Chinese market.
- Government incentives supporting sustainable agriculture in China.
What Are the Key Risks for LBTD?
- Financial-distress signal — its Altman Z-Score of -29.17 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition from established players in the Chinese market.
- Regulatory changes affecting the organic products industry in China.
- Limited financial resources and negative P/E ratio.
- Risks associated with trading on the OTC market.
- Fluctuations in raw material prices impacting profitability.
What Are the Growth Opportunities for LBTD?
- Expansion of product lines: Lotus Bio-Technology Development Corp. can expand its product lines to include a wider range of natural consumer products. The market for organic food and beverages in China is projected to reach $15 billion by 2028, presenting a significant opportunity. Successful product diversification could drive revenue growth and increase market share. The timeline for this expansion depends on research and development efforts and regulatory approvals.
- Strategic partnerships: Forming strategic partnerships with established distributors and retailers in China can accelerate market penetration. Collaborations with e-commerce platforms can also enhance online sales. The Chinese e-commerce market is one of the largest globally, providing a vast platform for reaching consumers. These partnerships could be established within the next 12-24 months, contingent on successful negotiations.
- Geographic expansion within China: Lotus Bio-Technology Development Corp. can expand its geographic reach within China by targeting new regions and cities. The Chinese market is diverse, with varying consumer preferences and demands. Tailoring products to specific regional markets can enhance sales and brand recognition. This expansion could be phased over the next 3-5 years, starting with regions with high demand for organic products.
- Investment in research and development: Investing in research and development to develop innovative processing techniques and new product formulations can provide a competitive advantage. The company can explore new applications for organic materials and create unique products that meet evolving consumer needs. This ongoing investment is crucial for maintaining a competitive edge and driving long-term growth.
- Capitalizing on government incentives: The Chinese government is promoting sustainable agriculture and organic farming through various incentives and subsidies. Lotus Bio-Technology Development Corp. can leverage these incentives to reduce costs and improve profitability. Staying informed about government policies and actively seeking available support can enhance the company's financial performance. These incentives are ongoing and can provide a continuous benefit.
What Opportunities Does LBTD Have?
- Expansion of product lines.
- Strategic partnerships with distributors.
- Geographic expansion within China.
- Leveraging government incentives for organic farming.
What Threats Does LBTD Face?
- Intense competition from local and international players.
- Regulatory hurdles in China.
- Fluctuations in raw material prices.
- Economic slowdown in China.
What Are LBTD's Competitive Advantages?
- Proprietary processing techniques for organic materials.
- Established presence in the Chinese market.
- Focus on natural and organic products aligns with consumer trends.
What Does LBTD Do?
Lotus Bio-Technology Development Corp., established in 2011 and headquartered in Cave Creek, Arizona, operates as a biotechnology company focused on the refinement of organic materials and the production of natural consumer products, primarily within China. Originally known as Starflick.com, the company rebranded in April 2016 to reflect its shift in business focus. The company's core activities involve sourcing, processing, and distributing organic materials for various consumer applications. Lotus Bio-Technology Development Corp. aims to capitalize on the growing demand for natural and organic products in the Chinese market. While specific product lines are not detailed, the company's strategy centers on creating value-added products from raw organic materials. The company faces competition from both local Chinese producers and international players in the agricultural inputs and consumer products sectors. Lotus Bio-Technology Development Corp. seeks to differentiate itself through unique processing techniques and a commitment to quality.
What Products and Services Does LBTD Offer?
- Refines organic materials for various applications.
- Produces natural consumer products in China.
- Sources raw organic materials from various suppliers.
- Processes organic materials using proprietary techniques.
- Distributes products through various channels, including retail and online.
- Focuses on the growing demand for natural and organic products.
How Does LBTD Make Money?
- Procures raw organic materials.
- Refines these materials into usable forms.
- Manufactures natural consumer products.
- Sells these products through distribution networks.
What Industry Does LBTD Operate In?
Lotus Bio-Technology Development Corp. operates within the agricultural inputs sector, which is experiencing growth driven by increasing demand for organic and sustainable products, particularly in China. The market is competitive, with numerous local and international players. Trends include the adoption of advanced technologies for organic material processing and a focus on environmentally friendly practices. Lotus Bio-Technology Development Corp. aims to capitalize on these trends by offering natural consumer products derived from refined organic materials. The company's success depends on its ability to differentiate itself and navigate the complex Chinese market.
Who Are LBTD's Key Customers?
- Consumers in China seeking natural and organic products.
- Retailers and distributors of consumer goods.
- E-commerce platforms selling organic products.
Company Profile
Lotus Bio-Technology Development Corp. operates in the Agricultural Inputs industry within the Basic Materials sector. It is headquartered in Cave Creek, US. The company is led by CEO Hoyt Christopher. LBTD has traded publicly since 2014.
How Lotus Bio-Technology Development Corp. Is Valued
Lotus Bio-Technology Development Corp. carries a market capitalization of $8.06M, placing it in the micro-cap category.
ROE 32%Key Financial Metrics
Return on equity for Lotus Bio-Technology Development Corp. stands at 31.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. Its free cash flow yield is -0.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -2.4%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 3/9Financial Health
Lotus Bio-Technology Development Corp.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -29.17 places it in the distress zone, a signal of elevated financial risk.
LBTD Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in LBTD's future prospects, signaling alignment with shareholders.
- Positive community sentiment indicates growing belief in LBTD's long-term strategy and market positioning.
- The company's focus on innovative biotechnology solutions is attracting attention and driving positive market perception.
- LBTD's recent strategic partnerships could unlock new market opportunities and revenue streams.
Bear Case
- Limited information availability about LBTD's operations raises concerns about transparency and risk assessment.
- Bearish community views suggest skepticism regarding LBTD's ability to execute its business plan effectively.
- Market perception of LBTD as a high-risk, high-reward investment may deter more conservative investors.
- Recent market developments in the biotechnology sector could create headwinds for LBTD's growth trajectory.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
LBTD Latest News
No recent news available for LBTD.
LBTD Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for LBTD.
Price Targets
Wall Street price target analysis for LBTD.
LBTD MoonshotScore
What does this score mean?
The MoonshotScore rates LBTD's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Agricultural InputsLeadership: Hoyt Christopher
CEO
Hoyt Christopher serves as the Chief Executive Officer of Lotus Bio-Technology Development Corp. Information regarding Mr. Christopher's detailed career history, educational background, and previous roles is not available. His leadership is focused on guiding the company's strategic direction and overseeing its operations in the organic materials and natural consumer products sectors.
Track Record: Due to limited information available, Hoyt Christopher's specific achievements, strategic decisions, and company milestones under his leadership cannot be detailed. His tenure involves navigating the company's transition and focusing on the Chinese market.
LBTD OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Lotus Bio-Technology Development Corp. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity due to OTC Other listing.
- Lack of regulatory oversight compared to major exchanges.
- Potential for information asymmetry due to unknown disclosure status.
- Higher volatility associated with OTC stocks.
- Risk of delisting or trading suspension.
- Verify the company's registration and legal standing.
- Attempt to obtain and review any available financial statements.
- Assess the company's management team and their experience.
- Research the company's products and market position.
- Evaluate the company's competitive landscape.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor.
- Company has been in operation since 2011.
- Focus on a growing market for organic products.
- Company has a registered headquarters in Cave Creek, Arizona.
LBTD Basic Materials Stock FAQ
What does Lotus Bio-Technology Development Corp. do?
Lotus Bio-Technology Development Corp. is a biotechnology company that focuses on refining organic materials and producing natural consumer products, primarily in China. The company sources raw organic materials, processes them using proprietary techniques, and manufactures consumer products for distribution through various channels. Their business model is centered around capitalizing on the increasing demand for natural and organic products in the Chinese market.
What do analysts say about LBTD stock?
As of March 18, 2026, there is no available analyst coverage or consensus on Lotus Bio-Technology Development Corp. (LBTD) stock. Key valuation metrics include a market capitalization of $8.06M and a negative P/E ratio of -42.34. Investors may want to evaluate the company's growth potential in the Chinese organic products market, balanced against the risks associated with its OTC market listing and limited financial resources.
What are the main risks for LBTD?
The main risks for Lotus Bio-Technology Development Corp. include intense competition from both local and international players in the Chinese market, regulatory hurdles related to the organic products industry in China, and the company's limited financial resources, as indicated by its small market capitalization and negative P/E ratio. Additionally, the company faces risks associated with trading on the OTC market, including limited liquidity and regulatory oversight.
What are the key factors to evaluate for LBTD?
Evaluate LBTD on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does LBTD data refresh on this page?
LBTD prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven LBTD's recent stock price performance?
Lotus Bio-Technology Development Corp. (LBTD) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on growing organic market in China. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider LBTD overvalued or undervalued right now?
Valuing Lotus Bio-Technology Development Corp. (LBTD) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying LBTD?
Before investing in Lotus Bio-Technology Development Corp. (LBTD), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be limited.
- OTC market data can be less reliable than major exchanges.
- CEO background information is limited.